Heritable Skeletal Disorders Arising from Defects in Processing and Transport of Type I Procollagen from the ER: Perspectives on Possible Therapeutic Approaches

Author(s):  
Meritxell B. Cutrona ◽  
Niamh E. Morgan ◽  
Jeremy C. Simpson

2021 ◽  
Vol 11 (2) ◽  
pp. 75 ◽  
Author(s):  
Britt Delnoy ◽  
Ana I. Coelho ◽  
Maria Estela Rubio-Gozalbo

Type I (classic) galactosemia, galactose 1-phosphate uridylyltransferase (GALT)-deficiency is a hereditary disorder of galactose metabolism. The current therapeutic standard of care, a galactose-restricted diet, is effective in treating neonatal complications but is inadequate in preventing burdensome complications. The development of several animal models of classic galactosemia that (partly) mimic the biochemical and clinical phenotypes and the resolution of the crystal structure of GALT have provided important insights; however, precise pathophysiology remains to be elucidated. Novel therapeutic approaches currently being explored focus on several of the pathogenic factors that have been described, aiming to (i) restore GALT activity, (ii) influence the cascade of events and (iii) address the clinical picture. This review attempts to provide an overview on the latest advancements in therapy approaches.







1989 ◽  
Vol 264 (19) ◽  
pp. 11336-11345 ◽  
Author(s):  
Y Hojima ◽  
J A McKenzie ◽  
M van der Rest ◽  
D J Prockop


2014 ◽  
Vol 72 ◽  
pp. 154-161 ◽  
Author(s):  
Hsiu-Mei Chiang ◽  
Chien-Wen Chen ◽  
Tzu-Yu Lin ◽  
Yueh-Hsiung Kuo


Sign in / Sign up

Export Citation Format

Share Document